SCHEMBL6089872

SCHEMBL6089872

CSc1ccc(-c2c(C(=O)O)n(Cc3cccc(Cl)c3)c3ccc(-c4ccc(C(C)(C)C)cc4)cc23)cc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 7/20 0.59
PTGES O14684 2/20 0.46
CCR9 P51686 2/20 0.42
EDNRB P24530 4/20 0.42
EDNRA P25101 4/20 0.42
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
ALOX12 P18054 1/20 0.41
PPARG P37231 1/20 0.41
RECQL P46063 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTGES2 Q9H7Z7 3/20 0.41
PLA2G2A P14555 1/20 0.40
TBXA2R P21731 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2810671 0.86 SERPINE1 (0.59) SERPINE1EDNRBEDNRAPPARG
SCHEMBL5738857 0.85 SERPINE1 (0.56) SERPINE1PTGESCCR9EDNRBEDNRA
SCHEMBL5812761 0.85 PTGES (0.65) SERPINE1PTGESEDNRBEDNRAPPARG
SCHEMBL6093339 0.82 SERPINE1 (0.61) SERPINE1PTGESEDNRBEDNRAMEN1
SCHEMBL6091652 0.78 SERPINE1 (0.54) SERPINE1PTGESCCR9PPARGPTGES2
SCHEMBL4092414 0.78 PTGES (0.72) SERPINE1PTGESCCR9EDNRBEDNRA
SCHEMBL6092174 0.77 THRB (0.44) SERPINE1PTGESMEN1CYP3A4MAPT
SCHEMBL6091490 0.76 TP53 (0.47) PTGESEDNRBEDNRAMEN1KMT2A
SCHEMBL2807015 0.76 SERPINE1 (0.62) SERPINE1PTGESEDNRBEDNRAPPARG
SCHEMBL2810203 0.76 SERPINE1 (0.62) SERPINE1EDNRBEDNRAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160879-A1 Indoles useful in the treatment of inflammation BIOLIPOX AB (SE) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160879-A1 Indoles useful in the treatment of inflammation IDO1, PTGS1, IDO2 SERPINE1 508/4885PTGES 4/4885CCR9 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.